Your search for Warfarin returned 11 results

Significant reductions were seen in dementia risk for rivaroxaban, apixaban, and dabigatran versus warfarin in network meta-analysis

Balfaxar is a non-activated 4 factor prothrombin complex concentrate containing vitamin K-dependent factors.

Quality improvement effort tied to decrease in major bleeding without increase in thrombotic events

During extended treatment, bleeding risk was similar for apixaban and rivaroxaban.

Findings seen among adults prescribed warfarin, DOACs beyond 6 months after acute venous thromboembolism.

No reduction seen in risk of antithrombotic events but increased risk of major and minor bleeding.

Tecarfarin is a novel oral vitamin K antagonist with a similar mechanism of action to warfarin, though it is metabolized differently.

Apixaban is a direct oral anticoagulant that relies less on kidney excretion.

Guideline addresses management of anticoagulants, antiplatelets during acute gastrointestinal bleeding and in the elective endoscopy setting

Risks for diabetes complications, mortality lower with non-vitamin K antagonist oral anticoagulants versus warfarin